Total Addressable Market, in Management's Own Words

Every total addressable market figure in a filing is a management construction. The number matters less than what surrounds it: the denominator management chose, the penetration rate it's willing to name, and whether it's sizing an opportunity or setting the scale for a different argument entirely. SeventhBiz pulls these claims verbatim, tagged to the speaker, the filing or call, and the period, then reads them against each other across industries.

Some Figures Are Just Scale

ServiceNow describing a "$600 billion plus" market for enterprise AI workflow, or Snowflake calling observability "a $50 billion-plus market," are framing numbers that establish scale and move on. MongoDB cites the same IDC forecast in consecutive fiscal-quarter filings, and the forecast itself moved between quotes.

"the worldwide Database Management Software market was $108 billion in 2025, and is expected to grow to approximately $193 billion in 2030. This represents a 12% five-year compound annual growth rate." (MDB)

One quarter earlier, the same 10-Q line cited $93 billion growing to $169 billion by 2029. Tracked side by side, that restatement isn't noise. It's the underlying research firm revising its own forecast, and a company that keeps citing an external source is only as current as that source's latest update.

Penetration Rate Turns a Number Into a Runway

Intuit gave two TAM figures on the same call: a "nearly $90 billion" mid-market opportunity with no penetration attached, and a business-platform TAM where management named exactly how much room it believes remains.

"We have a nearly $200 billion total addressable market, which is only penetrated by 7%." (INTU)

That second claim is the one worth building a model around. Paylocity discloses a narrower version of the same idea, a "realized target addressable market" of $22.5 billion built from what its clients already buy rather than a category-wide estimate. Atlassian bounds its opportunity even tighter:

"Our addressable market figures of $14 billion within the existing customer base without changing any products or pricing, et cetera, that there is a huge amount of upside opportunity still for us to go out and capture." (TEAM)

Neither Paylocity nor Atlassian is claiming a market. Both are sizing an expansion inside a customer base they already have, which is a fundamentally different and more testable claim than a top-down estimate.

Category-Level Claims Read Differently in Consumer

Outside software, TAM disclosures tend to get smaller and more specific, which makes them easier to verify. On its fiscal Q4 earnings call, The Marzetti Company sized the U.S. mayo category to frame the Bachan's Japanese mayo launch, then used an adjacent category as a comparison point.

"the mayo category is about $3.4 billion. Barbecue sauce category is just for a frame of reference, is a little bit bigger than $1 billion." (MZTI)

A quarter earlier, management sized the dip cup category at roughly $200 million and disclosed a 75%-plus share within it. Three numbers, three different distances from Marzetti's own business: an entry it's making, a category it's using for scale, and a niche it already dominates.

Definitive Healthcare discloses the same discipline in a single sentence:

"our estimated current total addressable market of over $11 billion that includes a more focused serviceable addressable market of approximately $7 billion" (DH)

Doximity did the reverse on two calls three months apart, sizing overall U.S. paid search at roughly $19 billion, then the pharma-specific slice at a narrower figure with a caveat management put on the record:

"The overall Google paid search spend by pharma is in the $14 billion range. I mean it's a very big number, but that does include direct-to-consumer and some other categories that we probably won't play in." (DOCS)

Omnicell paired its institutional pharmacy market size with a count of businesses servicing it, a market-structure disclosure most TAM figures don't bother to include:

"The market size of the institutional pharmacies industry in the U.S. is $24 billion with 1,100 businesses servicing this sector" (OMCL)

Not Every Big Number Is a TAM Claim

GoodRx's 10-K cites the U.S. healthcare market to argue the sector is too large and fragmented for consumers to navigate on their own:

"Despite the approximately $5.3 trillion U.S. healthcare market being one of the largest sectors of the U.S. economy, it remains opaque and highly fragmented for consumers." (GDRX)

That's a scale-setting figure for a fragmentation argument, not an addressable-market claim, and treating it as one would overstate what the company is actually saying. Separating the two is part of the extraction, not an afterthought to it.

Pulled individually, none of these numbers is remarkable. Stacked across enterprise software, consumer staples, and healthcare services, they form a comparison set: which managements bound their opportunity with a penetration rate, which size an expansion inside their existing customer base, and which cite a figure that was never a TAM claim at all.